Seres Therapeutics, Inc. Property, Plant and Equipment, Gross
Seres Therapeutics, Inc. (MCRB) had Property, Plant and Equipment, Gross of $61.09 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $61.09M.
- 2026-03-31: Property, Plant and Equipment, Gross $64.25M.
- 2025-12-31: Property, Plant and Equipment, Gross $64.25M.
- 2025-09-30: Property, Plant and Equipment, Gross $64.95M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $61.09M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $64.25M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $64.25M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $64.95M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $64.95M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $64.82M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $64.73M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $64.74M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $71.61M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $71.51M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $66.69M 10-K · filed 2025-03-13 | $73.59M 10-K · filed 2024-03-05 |
| 2023-09-30 | $73.22M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $71.99M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $70.75M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $68.03M 8-K · filed 2024-08-15 | |
| 2022-09-30 | $64.75M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $63.04M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $60.90M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $58.21M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $56.07M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $52.27M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $49.38M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $48.22M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $47.54M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $47.54M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $47.38M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $47.24M 10-K · filed 2021-03-02 | |
| 2019-09-30 | $47.10M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $47.01M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $46.72M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $46.59M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $46.39M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $46.24M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $45.85M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $45.37M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $44.26M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $43.48M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $43.00M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $41.30M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $38.05M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $29.22M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $17.48M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $8.76M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $5.22M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $3.81M 10-Q · filed 2015-08-10 | |
| 2014-12-31 | $1.55M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |